top of page


UK MHRA approves Incyte's Zynyz for advanced anal cancer as NICE backs NHS access
The UK MHRA has authorised Incyte's Zynyz with carboplatin and paclitaxel for advanced anal cancer, accompanied by a positive NICE access recommendation and Phase III evidence of improved median overall survival.

nuaxia
4 days ago2 min read


NICE backs Padcev and Keytruda combination around surgery for muscle-invasive bladder cancer
NICE has issued positive final draft guidance for perioperative Padcev and Keytruda in muscle-invasive bladder cancer, potentially expanding NHS treatment access before and after surgery for eligible patients regardless of cisplatin suitability.

nuaxia
5 days ago2 min read


Scotland backs UCB's Zilbrysq while NICE appraisal in England remains unresolved
The differing reimbursement positions highlight how health technology assessment decisions can diverge across UK nations, affecting the timing of patient access to new medicines.

nuaxia
Aug 132 min read


NICE Recommends First Non-Invasive Endometriosis Diagnostic Tools for NHS Use
EndoSure and Ziwig Endotest will be introduced as complementary diagnostic options, aiming to reduce delays in diagnosis for millions of women affected by endometriosis.

nuaxia
Jul 93 min read
bottom of page